These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4013147)
21. [Subacute and chronic cerebrovascular disorders. Diagnostic and therapeutic aspects]. Fischer B; Fischer U Fortschr Med; 1973 Mar; 91(9):369-73. PubMed ID: 4695450 [No Abstract] [Full Text] [Related]
22. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age]. Giovanardi F; Bisceglia G Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003 [No Abstract] [Full Text] [Related]
23. [Effect of a vasoactive agent on brain circulation]. Haragus S; Muresan IG; Schneider E Wien Med Wochenschr; 1972 Mar; 122(11):152-7. PubMed ID: 5047084 [No Abstract] [Full Text] [Related]
24. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease]. Kuiper MA; Zwaan WA; Wolters EC Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892 [No Abstract] [Full Text] [Related]
25. [Internal therapy of aging processes of the brain and its vessels]. Gottstein U Wien Klin Wochenschr; 1969 Jun; 81(24):441-6. PubMed ID: 5351157 [No Abstract] [Full Text] [Related]
26. [The treatment of Parkinson tremors and forms of extrapyramidal tremors with methixene. A multicenter study]. Volles E; Fredrich H Med Welt; 1983 Jun; 34(24):707-9. PubMed ID: 6888239 [No Abstract] [Full Text] [Related]
30. [Treatment of patients with initial manifestations of cerebrovascular insufficiency in atherosclerosis]. Kanareĭkin KF; Manvelov LS; Shvedkov VV Klin Med (Mosk); 1994; 72(1):56-60. PubMed ID: 8196329 [No Abstract] [Full Text] [Related]
31. [ What drug strategies are advisable for patients with advanced-stage Parkinson's]. Brefel-Courbon C Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046 [No Abstract] [Full Text] [Related]
32. Combined treatment in Parkinson's disease. Wheatley D Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232 [No Abstract] [Full Text] [Related]
33. The contribution of haemodynamic investigations to the study of cerebral vascular pathology. Lazorthes G; Géraud J; Bès A Triangle; 1970; 9(7):250-7. PubMed ID: 5521222 [No Abstract] [Full Text] [Related]
34. Drugs for Parkinson's Disease. Treat Guidel Med Lett; 2004 Jun; 2(22):41-6. PubMed ID: 15529113 [No Abstract] [Full Text] [Related]
35. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years. Hunyi L Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929 [No Abstract] [Full Text] [Related]
36. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Parkes JD; Marsden CD; Rees JE; Curzon G; Kantamaneni BD; Knill-Jones R; Akbar A; Das S; Kataria M Q J Med; 1974 Jan; 43(169):49-61. PubMed ID: 4822972 [No Abstract] [Full Text] [Related]
37. [Effect of antianginal agents on the cerebral circulatory indices in cerebral arteriosclerosis]. Eninia GI; Smeltere ES; Godlevska MA; Logina IP Klin Med (Mosk); 1985 Sep; 63(9):45-8. PubMed ID: 4068626 [No Abstract] [Full Text] [Related]
38. [Experimental investigations on drug induced improvement of brain metabolism]. Köhler W Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086 [No Abstract] [Full Text] [Related]
39. [Effective therapy option in the late phase of Parkinson disease: subcutaneous apomorphine]. Krankenpfl J; 2005; 43(7-10):241. PubMed ID: 16515311 [No Abstract] [Full Text] [Related]
40. [Therapeutic experience with the use of piritinol (Encephabol) in geriatrics]. Romano F Minerva Med; 1970 Jun; 61(51):2875-7. PubMed ID: 5432045 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]